Gene Therapy for CNS Disorders: Global Market Outlook 2019-2023 with Biogen, Bluebird Bio, Novartis, Pfizer, and Voyager Therapeutics Dominating - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Apr 23, 2019--The "Global Gene Therapy for CNS Disorders Market 2019-2023" report has been added to ResearchAndMarkets.com"s offering.
